Co-Diagnostics Inc

CODX

Company Profile

  • Business description

    Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

  • Contact

    2401 South Foothill Drive
    Salt Lake CityUT84109
    USA

    T: +1 801 438-1036

    https://www.codiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    132

Stocks News & Analysis

stocks

National Australia Bank earnings: Standing ground in business lending, but no earnings growth

Our view of the prospects for NAB shares.
stocks

Progress in UK expansion for undervalued ASX share

Guidance reaffirmed and UK implementation on track.
stocks

The sectors set to soar on government spending

Governments worldwide love to spend more money, and there are no signs that it will change any time soon.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,031.7045.20-0.50%
CAC 407,950.18124.05-1.54%
DAX 4023,569.96164.06-0.69%
Dow JONES (US)46,987.10323.90-0.68%
FTSE 1009,646.0089.78-0.92%
HKSE26,241.83244.07-0.92%
NASDAQ23,004.54495.26-2.11%
Nikkei 22550,276.37607.31-1.19%
NZX 50 Index13,599.2122.400.16%
S&P 5006,728.808.480.13%
S&P/ASX 2008,769.7040.80-0.46%
SSE Composite Index3,997.5610.20-0.25%

Market Movers